ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
ZBIO
67 hedge funds and large institutions have $257M invested in Zenas BioPharma, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+2
Holders Change %
+3.08%
% of All Funds
0.91%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
14
Reduced
20
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.46M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$4.86M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$3.71M |
| 4 |
EP
Eversept Partners
New York
|
+$2.16M |
| 5 |
CCM
Catalio Capital Management
New York
|
+$853K |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$6.09M |
| 2 |
Morgan Stanley
New York
|
-$2.21M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.07M |
| 4 |
Millennium Management
New York
|
-$1.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$876K |
